The past 5–10 years have brought in a new era in the care of patients with thyroid cancer,
with the introduction of transformative diagnostic and management options. Several …

Importance Approximately 43 720 new cases of thyroid carcinoma are expected to be
diagnosed in 2023 in the US. Five-year relative survival is approximately 98.5%. This review …

The number of cancer survivors continues to increase in the United States due to the growth
and aging of the population as well as advances in early detection and treatment. To assist …

Context Low-risk differentiated thyroid cancer (DTC) is overdiagnosed, but true incidence
has increased as well. Owing to its excellent prognosis with low morbidity and mortality …

Tumours can arise from thyroid follicular cells if they acquire driver mutations that
constitutively activate the MAPK signalling pathway. In addition, a limited set of additional …

Purpose: The determinants of response or resistance to radioiodine (RAI) are unknown. We
aimed to identify genomic and transcriptomic factors associated with structural responses to …

Background: Before the development of antithyroid drugs in the 1940s, treatment of Graves'
hyperthyroidism was primarily surgical. Surgical mortality was quite variable, but a …

Background We aimed to investigate whether the risk of second primary malignancy (SPM)
in patients with thyroid cancer (TC) receiving radioactive iodine (RAI) therapy rises in a …

Differentiated thyroid carcinoma (DTC) is the most common endocrine cancer. Particularly
the incidence of small clinically indolent tumors has been increasing significantly during the …

Objective This review article summarises the latest evidence for preventive central lymph
node dissection in patients with papillary thyroid cancer taking into account the possible …